Abstract
Ever since Thomas Lauder-Brunton first introduced amylnitrate into clinical medicine, nitrovasodilators of different classes have been extensively used in the medical treatment of angina pectoris, myocardial infarction and heart failure. Understanding the mechanisms of action of nitrates has been greatly expanded in the last decade, particularly since the discovery of endothelium-dependent relaxation and its mediator, the endogenous nitrate, NO.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Lüscher, T.F. (1993). From Thomas Lauder-Brunton to the Endogenous Nitrate. In: van Gilst, W.H., Lie, K.I. (eds) Neurohumoral Regulation of Coronary Flow. Developments in Cardiovascular Medicine, vol 150. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1900-9_10
Download citation
DOI: https://doi.org/10.1007/978-94-011-1900-9_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4839-2
Online ISBN: 978-94-011-1900-9
eBook Packages: Springer Book Archive